Beta Bionics, Inc.
- BBNX
- NASDAQ
- Medical devices
- Artificial Pancreas (iLet)
- Diabetes Management Tech
$16.35
Today −5.55%Quote Oct 16, 2026, 08:00 PM UTC
−23.71%over the last month
Max drawdown −28.3%From 1-month high −28.3%3 months −8.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$735.6M
Quote Oct 16
Next earnings
Oct 27
Expected, not confirmed
Analyst target
$24.75
+51.4% from here
Floor
$15.64
4.4% below price
Where the price sits
8 analysts
Analyst range, low to high
$16.00$30.00
- Price $16.35
- Resistance $16.71
- Consensus $24.75
The price is right under resistance. Analysts' average target sits about 51% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BBNXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical devices
Employees
422